NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $202,348 | -51.2% | 2,230 | -54.5% | 0.02% | -46.5% |
Q2 2022 | $415,000 | -3.5% | 4,904 | +0.1% | 0.04% | +10.3% |
Q1 2022 | $430,000 | -3.2% | 4,898 | -3.6% | 0.04% | +18.2% |
Q4 2021 | $444,000 | +6.7% | 5,081 | -0.1% | 0.03% | -2.9% |
Q3 2021 | $416,000 | -10.7% | 5,086 | -0.5% | 0.03% | -12.8% |
Q2 2021 | $466,000 | +11.5% | 5,111 | +4.5% | 0.04% | +2.6% |
Q1 2021 | $418,000 | -12.4% | 4,889 | -3.2% | 0.04% | -19.1% |
Q4 2020 | $477,000 | -1.2% | 5,051 | -9.1% | 0.05% | -13.0% |
Q3 2020 | $483,000 | +1.0% | 5,554 | +1.5% | 0.05% | -5.3% |
Q2 2020 | $478,000 | +4.4% | 5,473 | -1.5% | 0.06% | -10.9% |
Q1 2020 | $458,000 | -54.7% | 5,556 | -47.9% | 0.06% | +20.8% |
Q4 2019 | $1,010,000 | +240.1% | 10,671 | +212.6% | 0.05% | +32.5% |
Q3 2019 | $297,000 | – | 3,414 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |